Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Current Leases (2018 - 2024)

Solid Biosciences' Current Leases history spans 7 years, with the latest figure at $1.1 million for Q3 2024.

  • For Q3 2024, Current Leases fell 43.1% year-over-year to $1.1 million; the TTM value through Sep 2024 reached $1.1 million, down 43.1%, while the annual FY2023 figure was $469000.0, 75.28% down from the prior year.
  • Current Leases for Q3 2024 was $1.1 million at Solid Biosciences, up from $525000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $2.0 million in Q4 2020 and bottomed at $191000.0 in Q1 2020.
  • The 5-year median for Current Leases is $1.1 million (2024), against an average of $1.0 million.
  • The largest annual shift saw Current Leases soared 974.73% in 2020 before it plummeted 88.29% in 2021.
  • A 5-year view of Current Leases shows it stood at $2.0 million in 2020, then plummeted by 36.82% to $1.3 million in 2021, then skyrocketed by 50.2% to $1.9 million in 2022, then plummeted by 75.28% to $469000.0 in 2023, then surged by 124.09% to $1.1 million in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Current Leases are $1.1 million (Q3 2024), $525000.0 (Q2 2024), and $496000.0 (Q1 2024).